Skip to main content
Article
79O Clinical performance of Immunoscore® in early colon cancer in the Asian population
Annals of Oncology (2020)
  • J. Galon, French Institute of Health and Medical Research
  • Y. Kawakami, Keio University
  • T. Torigoe, Sapporo Medical University
  • Y. Wang, Xi'an Jiaotong University
  • P.S. Patel, Biochemistry Research Division, The Gujarat Cancer and Research Institute, Asarwa Ahmedabad, India
  • H. Vora, Biochemistry Research Division, The Gujarat Cancer and Research Institute, Asarwa Ahmedabad, India
  • B. Mlecnik, French Institute of Health and Medical Research
  • F. Marliot, Immunomonitoring Platform, Laboratory of Immunology, Hôpital Européen Georges Pompidou, Paris, France
  • C.B. Bifulco, Providence Portland Medical Center
  • A. Lugli, University of Bern
  • I.D. Nagtegaal, Radboud University Nijmegen
  • A. Hartmann, University of Erlangen-Nuremberg
  • M. van den Eynde, Cliniques Universitaires Saint-Luc
  • M.H.A. Roehrl, University Health Network
  • P.S. Ohashi, University Health Network
  • E. Zavadova, First Faculty of Medicine, Charles University in Prague
  • F. Marincola, Refuge Biotechnologies, Refuge Biotechnologies, Menlo Park, CA, USA
  • P.A. Ascierto, Melanoma, Cancer Immunotherapy & Developmental Therapeutics, Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, Naples, Italy
  • B.A. Fox, Molecular & Tumor Immunology Department, Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center, Portland, OR, USA
  • F. Pagès, French Institute of Health and Medical Research
Publication Date
November 1, 2020
DOI
10.1016/J.ANNONC.2020.10.099
Citation Information
J. Galon, Y. Kawakami, T. Torigoe, Y. Wang, et al.. "79O Clinical performance of Immunoscore® in early colon cancer in the Asian population" Annals of Oncology Vol. 31 (2020)
Available at: http://works.bepress.com/carlo-bifulco/53/